Zevra Therapeutics Q1 2026 Earnings Strong EPS Beat Drives Stock Higher Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderthanExpected Loss as ClinicalStage Biotech Reports No Revenue AMTB Q1 2026 Earnings EPS Misses Estimate by Narrow Margin Stock Edges Higher JCTC Q3 2025 Earnings Loss Reported Stock Surges 1435 HNI Q1 2026 Earnings EPS Beats Estimates by 17 as Cost Controls Drive Profitability VYNE Q1 2026 Earnings Narrows Loss Substantially Exceeds Analyst Expectations CAR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement